LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/Legislation Introduced to Speed CMS Coverage of FDA Approved Devices
Legal & Regulatory and Reimbursement

Legislation Introduced to Speed CMS Coverage of FDA Approved Devices

June 8, 2016 1 min read Premium comments

Advertisement

Legislation Introduced to Speed CMS Coverage of FDA Approved Devices
Indiana U.S. Senator Dan Coats / Courtesy of senate.gov
Secondary

Novel medical devices declared safe and effective by the FDA can take up to three years before receiving Centers for Medicare and Medicaid (CMS) coverage and reimbursement. That’s a long time for elderly Medicare patients to wait for potential life-saving medical care.

The U.S. Senator from the “Orthopedic Capitol of the World” wants to change that.

On May 26, 2016, Indiana Republican Senator Dan Coats, a member of the Senate Finance Committee, introduced The Ensuring Patient Access to Critical Breakthrough Products Act. The legislation would establish a program to accelerate transitional coverage and payment for new technologies that offer breakthroughs for serious illnesses affecting Medicare beneficiaries. During the three-year period of the program, the therapy would obtain predictable reimbursement coverage, and CMS could specify what supplemental data (if any) would be required to continue coverage after the three-year period.

Currently, a new technology may pass the FDA’s expedited review program, but can then face the up to three-year process of navigating the coverage and reimbursement process established by CMS. Years pass before Medicare beneficiaries are able to access these approved medical breakthroughs. “These regulations also create a financial uncertainty that disincentivizes investment in new, groundbreaking research. The Coats legislation would make improvements to the outdated new technology add-on payment (NTAP) program, so barriers that limit patient access to valuable technologies would be removed, ” stated a press release from the Senator’s office.

“Researchers and entrepreneurs, including many in Indiana, regularly come up with groundbreaking new treatments for some of our worst illnesses, only to encounter government regulations that prevent many patients from receiving potentially life-saving care, ” said Coats. “This legislation would streamline the current process, allowing Medicare patients to receive new treatments while also ensuring proper safety and quality regulations are met.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy